Company intelligence / Profile preview

Lumiata

San Mateo, California, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

Lumiata developed an artificial intelligence platform that automates the ingestion and analysis of healthcare data to deliver predictive analytics for risk management and cost reduction in healthcare. The platform has been used by payers and providers to identify at-risk patients and manage costs across millions of patient records.

The company was acquired by Somatus in April 2022.

No clinical results as the company does not conduct clinical trials.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Ascend.io/AWS/Azure partnership for cloud-based data preparation extension

Beyond the preview

Go deeper on Lumiata.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lumiata.

Explore the full profile